Lv5
1190 积分 2024-12-24 加入
Antibody–drug conjugates in gynaecological cancers: opportunities and challenges
1天前
已完结
Orthogonal Conjugation via Endoglycosidase and Microbial Transglutaminase Enables Efficient Synthesis of Dual-Payload Antibody-Drug Conjugates
2天前
已完结
“Outstanding” ADC Candidates Emerge for SCLC, Other Cancers
5天前
已关闭
STEAP1-targeted strategies in advanced prostate cancer: a review on therapeutic and diagnostic implications
6天前
已完结
Strategic scaffold redesign of ecteinascidins: An approach for generating anticancer macrocycles
6天前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
6天前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
6天前
已完结
1804P APEX-01: First-in-human phase I/II study of ARX517 an anti- prostate-specific membrane antigen (PSMA) antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
6天前
已完结
Synthesis of Natural Ecteinascidins (ET-729, ET-745, ET-759B, ET-736, ET-637, ET-594) from Cyanosafracin B
6天前
已完结
皖公网安备34019202002308
